The US Senate committee has recently discussed a bill that focuses on addressing concerns related to China's BGI and WuXi Apptec in the field of genetics. The bill aims to target these Chinese companies and their involvement in genetic research and data collection.
BGI, a prominent genomics company based in China, has been under scrutiny due to its extensive genetic data collection practices. The company's activities have raised concerns about data privacy and potential misuse of genetic information.
